Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule.

Bishop MW, Yin H, Shimada H, Towbin AJ, Miethke A, Weiss B.

J Pediatr Hematol Oncol. 2014 Jan;36(1):e31-5. doi: 10.1097/MPH.0b013e3182847376.

PMID:
23528904
[PubMed - indexed for MEDLINE]
2.

Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.

Nakagawa A, Matsuoka K, Okita H, Iwafuchi H, Hori H, Kumagai M.

Pediatr Dev Pathol. 2011 Mar-Apr;14(2):87-92. doi: 10.2350/08-12-0579.1. Epub 2011 Feb 2.

PMID:
21288077
[PubMed - indexed for MEDLINE]
3.

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.

Chan EL, Harris RE, Emery KH, Gelfand MJ, Collins MH, Gruppo RA.

Pediatr Blood Cancer. 2007 Apr;48(4):479-82. Review.

PMID:
16333837
[PubMed - indexed for MEDLINE]
4.

Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment.

Boztug K, Kiely E, Roebuck DJ, Gaze M, Begent J, Brock P, Michalski A.

Pediatr Blood Cancer. 2006 Feb;46(2):253-7.

PMID:
15926157
[PubMed - indexed for MEDLINE]
5.

Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.

Bagatell R, Rumcheva P, London WB, Cohn SL, Look AT, Brodeur GM, Frantz C, Joshi V, Thorner P, Rao PV, Castleberry R, Bowman LC.

J Clin Oncol. 2005 Dec 1;23(34):8819-27.

PMID:
16314642
[PubMed - indexed for MEDLINE]
Free Article
6.

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.

Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL; International Neuroblastoma Risk Group.

J Clin Oncol. 2009 Jan 20;27(3):365-70. doi: 10.1200/JCO.2008.17.9184. Epub 2008 Dec 1.

PMID:
19047282
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Heterogeneity of the MYCN oncogene in neuroblastoma.

Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B.

Clin Cancer Res. 2009 Mar 15;15(6):2085-90. doi: 10.1158/1078-0432.CCR-08-1648. Epub 2009 Mar 10.

PMID:
19276282
[PubMed - indexed for MEDLINE]
Free Article
8.

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.

Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M.

Genome Biol. 2008 Oct 13;9(10):R150. doi: 10.1186/gb-2008-9-10-r150.

PMID:
18851746
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Locoregional MYCN-amplified neuroblastoma.

Morales La Madrid A, Volchenboum S, Gastier-Foster JM, Pyatt R, Liu D, Pytel P, Lavarino C, Rodriguez E, Cohn SL.

Pediatr Blood Cancer. 2012 Oct;59(4):736-8. doi: 10.1002/pbc.24003. Epub 2012 Jan 1.

PMID:
22213566
[PubMed - indexed for MEDLINE]
10.

Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.

Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H.

Cancer. 2005 Jan 1;103(1):174-80.

PMID:
15549714
[PubMed - indexed for MEDLINE]
Free Article
11.

Bilateral adrenal neuroblastoma.

Pagès PM, Dufour C, Fasola S, Michon J, Boutard P, Gentet JC, Hartmann O.

Pediatr Blood Cancer. 2009 Feb;52(2):196-202. doi: 10.1002/pbc.21765.

PMID:
18951434
[PubMed - indexed for MEDLINE]
12.

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.

Schneiderman J, London WB, Brodeur GM, Castleberry RP, Look AT, Cohn SL.

J Clin Oncol. 2008 Feb 20;26(6):913-8. doi: 10.1200/JCO.2007.13.9493.

PMID:
18281664
[PubMed - indexed for MEDLINE]
Free Article
13.

Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

Weber A, Imisch P, Bergmann E, Christiansen H.

J Clin Oncol. 2004 Jul 1;22(13):2681-90.

PMID:
15226335
[PubMed - indexed for MEDLINE]
Free Article
14.

New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status.

Simon T, Spitz R, Faldum A, Hero B, Berthold F.

J Pediatr Hematol Oncol. 2004 Dec;26(12):791-6.

PMID:
15591897
[PubMed - indexed for MEDLINE]
15.

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H.

Cancer. 2001 Nov 15;92(10):2699-708.

PMID:
11745206
[PubMed - indexed for MEDLINE]
16.

The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma.

Souzaki R, Tajiri T, Teshiba R, Higashi M, Kinoshita Y, Tanaka S, Taguchi T.

Pediatr Surg Int. 2011 Mar;27(3):231-6. doi: 10.1007/s00383-010-2781-4.

PMID:
21046119
[PubMed - indexed for MEDLINE]
17.

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.

Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG.

J Clin Oncol. 2014 Oct 1;32(28):3169-76. doi: 10.1200/JCO.2014.56.1621. Epub 2014 Aug 25.

PMID:
25154816
[PubMed - indexed for MEDLINE]
18.

Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.

Tanaka S, Tajiri T, Noguchi S, Shono K, Ihara K, Hara T, Suita S.

J Pediatr Surg. 2004 Jan;39(1):63-8.

PMID:
14694373
[PubMed - indexed for MEDLINE]
19.

Management and outcome of stage 3 neuroblastoma.

Modak S, Kushner BH, LaQuaglia MP, Kramer K, Cheung NK.

Eur J Cancer. 2009 Jan;45(1):90-8. doi: 10.1016/j.ejca.2008.09.016. Epub 2008 Nov 6.

PMID:
18996003
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.

Ribatti D, Raffaghello L, Pastorino F, Nico B, Brignole C, Vacca A, Ponzoni M.

Int J Cancer. 2002 Dec 1;102(4):351-4.

PMID:
12402304
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk